Mistakes in respiratory treatment and a safe solution with spore probiotics

December 25, 2024 - 16:00
LiveSpo NAVAX An ear-nose-throat cleansing drop for infants and young children is a pioneering and safe product suitable for all ages, effective in preventing respiratory tract infections, helping reduce current antibiotic dependence.

Common mistakes in treating respiratory illnesses in children

Misusing antibiotics and nasal sprays/drops containing corticosteroids are two of the most common mistakes parents make when treating their children’s respiratory issues. Both types of medication, if not prescribed by a doctor and used incorrectly, can cause many side effects affecting users' health, especially in young children.

According to medical experts, common respiratory symptoms such as a sore throat, cough and fever do not always require antibiotics. Using antibiotics in these cases neither helps reduce the symptoms nor prevents side effects. Instead, it poses risks of drug-resistant bacteria, complicating future treatments.

The World Health Organization (WHO) has also issued warnings about the global antibiotic resistance crisis. It predicts that by 2050, around 10 million people could die each year due to drug-resistant bacteria—equivalent to one death every three seconds. At that point, even minor conditions like a simple cough or a small cut on the skin could be fatal.

Overusing antibiotics in respiratory treatment increases antibiotic resistance in children

Similarly, the misuse or overuse of nasal sprays/drops containing corticosteroids can become a 'double-edged sword', causing unpredictable consequences such as high blood pressure, cataracts or osteoporosis.

Supporting respiratory treatment with LiveSpo NAVAX nasal and throat cleansing solution

The LiveSpo NAVAX ear-nose-throat cleansing solution, formulated with spore probiotics, is designed for infants and young children. It helps reduce the risk of respiratory infections and boosts children's natural immunity, thus decreasing the need for antibiotics and minimising antibiotic misuse in treating respiratory conditions.

LiveSpo NAVAX – a pioneering, safe solution to reduce antibiotic use in respiratory treatment

LiveSpo NAVAX is an innovative product developed by LiveSpo Pharma, using proprietary pre-activation and spore refinement technology from the sixth generation of probiotics – currently the most advanced generation.

LiveSpo NAVAX for infants and children contains safe ingredients, consisting of saline solution (0.9% NaCl) with 24 billion bacillus spores per ten-tube box, completely free of corticosteroids, antibiotics or any other additives.

The product has been clinically tested to international standards by medical experts from the Institute of Preventive Medicine and Public Health and ENT specialists from Hanoi Medical University. The studies found no abnormal reactions or side effects throughout the testing process. Therefore, LiveSpo NAVAX is suitable for all users, including newborns, pregnant women and breastfeeding mothers.

In the context of weather changes and air pollution, respiratory diseases are increasing, especially acute respiratory infections caused by RSV & flu viruses. Using LiveSpo NAVAX is an optimal solution helping protect children's comprehensive respiratory health, contributing to reducing antibiotic dependence.

 

E-paper